Paola Nasta

Summary

Country: Italy

Publications

  1. ncbi request reprint "Immune activation, aging and gender" and progression of liver disease
    Paola Nasta
    Institute of Infectious and Tropical Diseases, University of Brescia
    Acta Biomed 82:115-23. 2011
  2. doi request reprint Insulin resistance impairs rapid virologic response in HIV/hepatitis C virus coinfected patients on peginterferon-alfa-2a
    Paola Nasta
    Institute of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy
    AIDS 22:857-61. 2008
  3. doi request reprint Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosis
    Francesca Gatti
    Institute of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy
    J Antimicrob Chemother 63:575-8. 2009
  4. doi request reprint HIV-related liver disease: ARV drugs, coinfection, and other risk factors
    Massimo Puoti
    Department of Infectious and Tropical Diseases, University of Brescia, AO Spedali Civili, Brescia, Italy
    J Int Assoc Physicians AIDS Care (Chic) 8:30-42. 2009
  5. ncbi request reprint Treating hepatitis C virus in HIV patients: are side effects a real obstacle?
    Francesca Gatti
    Department of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy
    AIDS Rev 9:16-24. 2007
  6. doi request reprint Hepatitis B virus and HIV coinfection in low-income countries: unmet needs
    Massimo Puoti
    Department of Infectious Diseases, University of Brescia, Italy
    Clin Infect Dis 46:367-9. 2008
  7. ncbi request reprint The burden of HIV and hepatitis C virus coinfection
    Massimo Puoti
    Department of Infectious Diseases, University of Brescia, Brescia, Italy
    Curr Opin HIV AIDS 2:460-5. 2007
  8. pmc Virological effectiveness and CD4+ T-cell increase over early and late courses in HIV infected patients on antiretroviral therapy: focus on HCV and anchor class received
    Davide Motta
    Institute of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy
    AIDS Res Ther 9:18. 2012
  9. ncbi request reprint Imported malaria in an HIV-positive traveler: a case report with a fatal outcome
    Alberto Matteelli
    Institute of Infectious and Tropical Diseases, University of Brescia, Italy
    J Travel Med 12:222-4. 2005
  10. ncbi request reprint Antiviral efficacy and genotypic resistance patterns of combination therapy with stavudine/tenofovir in highly active antiretroviral therapy experienced patients
    Andrea Antinori
    National Institute for Infectious Diseases L Spallanzani IRCCS, Roma
    Antivir Ther 11:233-43. 2006

Collaborators

Detail Information

Publications16

  1. ncbi request reprint "Immune activation, aging and gender" and progression of liver disease
    Paola Nasta
    Institute of Infectious and Tropical Diseases, University of Brescia
    Acta Biomed 82:115-23. 2011
    ..www.actabiomedica.it)..
  2. doi request reprint Insulin resistance impairs rapid virologic response in HIV/hepatitis C virus coinfected patients on peginterferon-alfa-2a
    Paola Nasta
    Institute of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy
    AIDS 22:857-61. 2008
    ..To investigate the association between insulin resistance and rapid virologic response...
  3. doi request reprint Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosis
    Francesca Gatti
    Institute of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy
    J Antimicrob Chemother 63:575-8. 2009
    ..Liver stiffness at baseline and alanine aminotransferase levels at baseline and during follow-up were measured in order to find a correlation between drug levels and liver fibrosis or hepatotoxicity...
  4. doi request reprint HIV-related liver disease: ARV drugs, coinfection, and other risk factors
    Massimo Puoti
    Department of Infectious and Tropical Diseases, University of Brescia, AO Spedali Civili, Brescia, Italy
    J Int Assoc Physicians AIDS Care (Chic) 8:30-42. 2009
    ..As more information about the mechanisms of drug related liver injury is known, clinicians will be better able to tailor therapies to suit individual situations, resulting in greater patient safety and outcomes...
  5. ncbi request reprint Treating hepatitis C virus in HIV patients: are side effects a real obstacle?
    Francesca Gatti
    Department of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy
    AIDS Rev 9:16-24. 2007
    ....
  6. doi request reprint Hepatitis B virus and HIV coinfection in low-income countries: unmet needs
    Massimo Puoti
    Department of Infectious Diseases, University of Brescia, Italy
    Clin Infect Dis 46:367-9. 2008
  7. ncbi request reprint The burden of HIV and hepatitis C virus coinfection
    Massimo Puoti
    Department of Infectious Diseases, University of Brescia, Brescia, Italy
    Curr Opin HIV AIDS 2:460-5. 2007
    ..Persons with HIV are frequently coinfected with hepatitis C virus. We review recent data on the epidemiology and natural history of hepatitis C in HIV-infected persons...
  8. pmc Virological effectiveness and CD4+ T-cell increase over early and late courses in HIV infected patients on antiretroviral therapy: focus on HCV and anchor class received
    Davide Motta
    Institute of Infectious and Tropical Diseases, University of Brescia, Brescia, Italy
    AIDS Res Ther 9:18. 2012
    ..abstract:..
  9. ncbi request reprint Imported malaria in an HIV-positive traveler: a case report with a fatal outcome
    Alberto Matteelli
    Institute of Infectious and Tropical Diseases, University of Brescia, Italy
    J Travel Med 12:222-4. 2005
    ..The importance of prevention of malaria in nonimmune travelers is stressed. Prevention of malaria in nonimmune travelers should be regarded as a priority area for clinical practice and operational research...
  10. ncbi request reprint Antiviral efficacy and genotypic resistance patterns of combination therapy with stavudine/tenofovir in highly active antiretroviral therapy experienced patients
    Andrea Antinori
    National Institute for Infectious Diseases L Spallanzani IRCCS, Roma
    Antivir Ther 11:233-43. 2006
    ..To evaluate antiviral efficacy of stavudine/tenofovir (d4T/TDF) backbone combination in late-line antiretroviral therapy, and to assess clinical and virological determinants of treatment success...
  11. ncbi request reprint Relative prognostic value of self-reported adherence and plasma NNRTI/PI concentrations to predict virological rebound in patients initially responding to HAART
    Andrea Antinori
    Istituto Nazionale per le Malattie Infettive, L Spallanzani IRCCS, Roma, Italy
    Antivir Ther 9:291-6. 2004
    ..6%) experienced virological rebound by 96 weeks. Both self-reported non-adherence and sub-optimal concentration were independently associated with a higher risk of virological rebound...
  12. ncbi request reprint The effect of HIV-1 resistance mutations after first-line virological failure on the possibility to sequence antiretroviral drugs in second-line regimens
    Franco Maggiolo
    Divisione di Malattie Infettive, Ospedali Riuniti, Bergamo, Italy
    Antivir Ther 11:923-9. 2006
    ..One of the more vigorous debates in the field of highly active antiretroviral therapy (HAART) is how to start it and what the optimal drug sequence is...
  13. doi request reprint Self-reported sexual dysfunction is frequent among HIV-infected persons and is associated with suboptimal adherence to antiretrovirals
    Maria Paola Trotta
    Istituto Nazionale per le Malattie Infettive, L Spallanzani IRCCS, Rome, Italy
    AIDS Patient Care STDS 22:291-9. 2008
    ..44; 95% CI 1.30-9.08). In conclusion, patients' perceived SD represents a relevant problem for HIV-infected persons treated with antiretrovirals and is strongly associated with suboptimal HAART adherence...
  14. ncbi request reprint Use of complementary and alternative medicine in HIV-infected subjects
    Vittorio Agnoletto
    LILA Lega Italiana per la Lotta contro l AIDS, Milan, Italy
    Complement Ther Med 14:193-9. 2006
    ..To compare the characteristics of HIV-infected subjects who had ever used with those who had never used Complementary and Alternative Medicine (CAM)...
  15. ncbi request reprint Illicit drug use: can it predict adherence to antiretroviral therapy?
    Michela Martini
    LILA Lega Italiana per la Lotta contro l AIDS, Italian League for the fight against AIDS National Research Centre, Milan, Italy
    Eur J Epidemiol 19:585-7. 2004
    ..42.3%), among the users of psychoactive pharmaceuticals and alcohol the percentage of high-compliant patients tended to be lower (respectively 26.6 and 30%), but the difference was not significant...
  16. ncbi request reprint Reasons for complementary therapies and characteristics of users among HIV-infected people
    Vittorio Agnoletto
    Lega Italiana per la Lotta contro l AIDS, Milan, Italy
    Int J STD AIDS 14:482-6. 2003
    ..0-36.4%). The most common expectations from CT were to improve energy and to prevent or alleviate the HAART side effects. This suggests that HIV-infected people expect not so much specific help as general support from CT...